Glenmark Pharmaceuticals Ltd.

GLENMARK Share PricePharmaceuticals & Drugs

₹1,811.5

1.1 (0.1%)

As on November 7, 2025

Exchange Scrips: BSE532296NSEGLENMARKISININE935A01035

Market Cap ₹ 51,428 Cr

P/E Ratio 48.82

Dividend Yield 0.14 %

Performance

Market performance

Open1,801.4

High1,829.4

Volumes5,53,200

Prev1,811.5

Low1,801.4

As on2025-11-07

Historical performance

1 Year High2,284.8

3 Year High2,284.8

5 Year High2,284.8

1 Year Low1,275.5

3 Year Low369.05

5 Year Low348.5

Fundamentals

Company Valuation

Market Cap (₹Cr)

51,428

Face Value (₹)

P/E Ratio

48.82

Dividend Yield

0.14 %

Investment Returns

1 Year

9.3%

3 Years

328.3%

5 Years

253.9%

10 Years

88.3%

Technicals

Indicators	Value	Signal
5-DMA	1,851.32	Bearish
10-DMA	1,842.93	Bearish
20-DMA	1,864.3	Bearish
50-DMA	1,954.62	Bearish
100-DMA	1,956.45	Bearish
200-DMA	1,697.71	Bullish

Shareholding Pattern

Field	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	198783	190204	192718	195053	193943
Government	4	4	4	3	3

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of 48.82.
3Y Stock Price CAGR of the stock is 62.7.
The stock has a beta of 0.6.
In the last financial year, the company had an EBITDA of ₹24651 Million.
The company generated revenue of ₹133217 Million in the previous financial year.

Glenmark Pharmaceuticals Ltd.

1811.51.1 (0.1%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1087008.7

No. of Shares: 600 (Approx)

Performance:8.7%

P/L: ₹87008.7

Top Gainers